Palomino Laboratories Inc.
CIK: 0001938569
Company Information
Industry Blank Checks
SIC Code 6770
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 12 E. 49TH STREET, NEW YORK, NY, 10017
Mailing Address 12 E. 49TH STREET, NEW YORK, NY, 10017
Phone (917) 200-3734
Fiscal Year End 1231
EIN 881619619
Financial Overview
FY2024
-$84K
Net Income
$29K
Total Assets
-$28K
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | January 23, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 8-K Current report of material events | October 30, 2025 | View on SEC |
| 4 Insider stock transaction report | October 27, 2025 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | October 27, 2025 | View on SEC |
| 4 Insider stock transaction report | October 9, 2025 | View on SEC |
| 4 Insider stock transaction report | October 9, 2025 | View on SEC |
| 4 Insider stock transaction report | October 9, 2025 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | October 8, 2025 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | October 7, 2025 | View on SEC |
IPO Filings
S-1 January 23, 2026
- Pioneering AI-powered diagnostic platforms for early disease detection, with a flagship lung cancer detection system (Dx-100) in Phase 3 clinical trials.
- Significant market opportunity in the global diagnostics market, projected to exceed $100 billion by 2030.
Related Companies
Companies in the same industry (SIC: 6770)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.